alexa Impact Of Diuretic Therapy On Renal Outcomes Of Chronic Kidney Disease Patients
ISSN: 2161-0959

Journal of Nephrology & Therapeutics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

12TH ANNUAL CONFERENCE ON Nephrology & Urology
JULY 06-07, 2017 KUALA LUMPUR, MALAYSIA

Yusra Habib Khan, Azmi Sarrif, Azreen Syazril Adnan, Amer Hayat Khan and Tauqeer Hussain Mallhi
University Sains Malaysia, Malaysia
Posters & Accepted Abstracts: J Nephrol Ther
DOI: 10.4172/2161-0959-C1-043
Abstract
Diuretic therapy has been mainstay of treatment in Chronic Kidney Disease (CKD) patients, primarily for hypertension and fluid overload. Apart from their beneficial effects, diuretic use is associated with adverse renal outcomes. Current study aimed to determine outcomes of diuretic therapy. A prospective observational study was conducted by inviting pre-dialysis CKD patients. Fluid overload was assessed by Bioimpedance Analysis (BIA). A total 312 patients (mean age 64.5±6.43) were enrolled. Among 144 (46.1%) diuretic users, furosemide and hydrochlorothiazide (HCTZ) were prescribed in 69 (48%) and 39 (27%) patients respectively, while 36 (25%) prescribed with combination therapy (furosemide plus HCTZ). Changes in BP, fluid compartments, eGFR decline and progression to RRT were assessed over a follow-up period of 1 year. Maximum BP control was observed with combination therapy (-19.3 mmHg, p<0.001) followed by furosemide (-10.6 mmHg with 80 mg thrice daily (p<0.001)), -9.3 mmHg with 40-60 mg (p<0.001) & -5.9 mmHg with 20-40 mg (p=0.02) while HCTZ offered minimal SBP control (-3.7 mmHg with 12.5-25 mg (p=0.04)). Decline in extracellular water (ECW) ranged from -1.5 L (p=0.01) with thiazide diuretics to -3.8 L (p<0.001) with combination diuretics. Decline in eGFR was maximum (-3.4 ml/min/1.73 m2, p=0.01) with combination diuretics and least with thiazide diuretics (-1.6 ml/min/1.73 m2, p=0.04). Progression to RRT was observed in 36 patients. It is cautiously suggested to discourage the use of diuretic combination therapy and high doses of single diuretic therapy. Prescribing of diuretics should be done by keeping in view benefit versus harm for each patient.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords